文献速递主动脉疾病

ANCHOR注册研究中短颈腹主动脉瘤患者内缝合动脉瘤修复的五年结局

Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry.
PubMed 文献 · J Vasc Surg · 2023-08-07

ANCHOR注册研究短颈监管队列纳入70例近端瘤颈长度≥4 mm且<10 mm的腹主动脉瘤患者,接受Heli-FX EndoAnchor系统联合Endurant支架行内缝合动脉瘤修复(ESAR)。5年全因死亡免除率68.5±6.2%,动脉瘤相关死亡免除率90.1±4.5%,任何血管内或外科二次手术免除率76.9±7.2%,破裂免除率95.6±3.2%。

要点

  • 5年全因死亡免除率68.5±6.2%,动脉瘤相关死亡免除率90.1±4.5%。
  • 5年任何二次手术免除率76.9±7.2%,破裂免除率95.6±3.2%。
  • 5年内8例检出9次IA型内漏,其中3次在下次随访前自行消退。

核心结论

  • 短颈队列接受Heli-FX EndoAnchor联合Endurant行ESAR后5年结局在近端瘤颈相关并发症、二次手术和瘤囊回缩方面结果令人鼓舞。
  • 作者认为该短颈患者ESAR回顾显示5年阳性结局,但需要对更大队列进行随访。

研究设计与样本

  • ANCHOR注册研究中提交监管机构用于Endurant短颈适应症批准的70例患者队列。
  • 患者肾下瘤颈长度≥4 mm且<10 mm。
  • 5年时该短颈队列临床随访依从率85%(28/33),影像随访依从率70%(23/33)。

主要发现

  • 短颈队列平均年龄71.3±8.1岁,女性占27.1%(19/70)。
  • Kaplan-Meier全因死亡免除率68.5±6.2%,动脉瘤相关死亡免除率90.1±4.5%,任何血管内或外科二次手术免除率76.9±7.2%,破裂免除率95.6±3.2%。
  • 5年内8例患者共检出9次IA型内漏,其中3次在下次随访前自行消退。
  • 2例患者发生肾脏并发症且未接受再次干预,5年内报告无器械移位。
  • 5年后与1个月测量值相比,68.2%(15/22)患者瘤囊回缩,13.6%(3/22)瘤囊稳定,18.2%(4/22)瘤囊直径增大。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需要对更大队列进行随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hostile aortic neck anatomies such as proximal short necks are known to put patients at an increased risk for type IA endoleaks, migration, and need for reinterventions. The Heli-FX EndoAnchor System was designed to improve seal of aortic stent grafts. Endosuture aneurysm repair (ESAR) using EndoAnchors with the Endurant stent graft has been shown to be safe and effective for the treatment of patients with short necks through one year. This study reports the 5-year patient outcomes of the Aneurysm Treatment using the Heli-FX EndoAnchor System Global Registry (ANCHOR) short neck regulatory cohort. METHODS: The 70 patients from the ANCHOR Registry were cohort submitted to regulators for approval of the Endurant short neck indication. Patients had an infrarenal neck length of ≥ 4 mm and <10 mm. At 5 years, this short neck cohort had clinical and imaging follow-up compliance rates of 85% (28/33) and 70% (23/33), respectively. RESULTS: The short neck cohort had a mean age of 71.3±8.1 years and was 27.1% (19/70) female. Kaplan Meier freedom from all-cause mortality was 68.5 ± 6.2%, freedom from aneurysm-related mortality was 90.1 ± 4.5%, freedom from any endovascular or surgical secondary procedure was 76.9 ± 7.2%, and freedom from rupture was 95.6 ± 3.2%. Eight patients had a total of nine type IA endoleaks detected through 5 years, of which three resolved spontaneously by the next follow-up visit. There were two patients with renal complications who did not undergo reintervention and there were no device migrations reported through 5 years. After 5 years, 68.2% of patients (15/22) had sac regression, 13.6% (3/22) had stable sacs, and 18.2% (4/22) had increased sac diameter as compared with their 1-month measurements. CONCLUSIONS: After ESAR treatment using Heli-FX EndoAnchors with Endurant, the 5-year outcomes of the short neck cohort from the ANCHOR registry had encouraging results with regards to proximal neck-related complications, secondary procedures, and sac regression. This review of ESAR in patients with short proximal necks showed positive outcomes through 5 years although follow-up of a larger cohort is necessary.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arko FR, Pearce BJ, Henretta JP, et al. Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry. J Vasc Surg. 2023. PMID: 37558144. doi:10.1016/j.jvs.2023.07.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。